ONT
NEUTRALOxford Nanopore Announces Major Shareholding Change
The biotechnology company has announced a change in major shareholding, with a US-based investment firm increasing its stake in the business.
Oxf Nanopore Technologies
119.40GBX
0.76%
Market Cap
1.15B
Volume
36.39M
1298% of avg
P/E Ratio
-0.08
EPS (TTM)
-14.43
Beta
0.98
Day Range
118.80p - 121.60p
52 Week Range
85.00p119.40p169.20p
119.40p
Upcoming Events
ONT
NEUTRALOxford Nanopore Director Increases Shareholding
The Chief Financial Officer of the biotechnology company has purchased additional shares through the company's Share Incentive Plan.
ONT
NEUTRALOxford Nanopore Technologies Announces Holding Change
The biotechnology company has announced a change in shareholding, with Baillie Gifford & Co reducing its stake in the firm.
ONT
NEUTRALOxford Nanopore Announces Changes to Remuneration Committee
The healthcare technology company has appointed a new Chair of its Remuneration Committee.
ONT
NEUTRALOxford Nanopore Announces Major Shareholding Change
The healthcare technology company has announced a change in its major shareholding, with a US-based investment firm increasing its stake in the business.
ONT
NEUTRALOxford Nanopore Provides Technology Update at London Calling Conference
The biotechnology company updates on its nanopore-based molecular sensing technology, including improvements to product performance, analytics, and long-term innovation pipeline.
ONT
NEUTRALOxford Nanopore Announces Director Share Purchases Under SIP
The biotechnology company has announced that a director has purchased shares under its employee share plan.
ONT
NEUTRALOxford Nanopore CEO Sells Shares to Cover Tax Liabilities
The CEO of the biotechnology company has sold a portion of his shares to cover tax liabilities, with the remaining shares retained.
ONT
NEUTRALOxford Nanopore Technologies Publishes Annual Report and AGM Notice
The biotechnology company has published its 2024 annual report and notice of 2025 annual general meeting.
ONT
NEUTRALOxford Nanopore Announces Holding Change
The biotechnology company has announced a change in shareholding, with EIT Oxford Holdings, LLC increasing its stake to 13.057600%.